Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Clarivate Extends Partnership With Verisim Life to Accelerate and De-risk Research and Drug Development

Wednesday, December 06, 2023

Clarivate Plc has introduced the VeriSIM Life Translational Index on Cortellis Drug Discovery Intelligence This integrated platform provides users with a range of predictive insights

Merck Introduces Innovative AI Solution for Seamless Integration of Drug Discovery and Synthesis

Wednesday, December 06, 2023

Merck a leading science and technology company has recently unveiled its groundbreaking AIDDISON drug discovery software This marks the introduction of the firstever softwareasaservice platform that bridges

Abbisko Therapeutics and Merck Finalize Licensing Agreement for Pimicotinib (ABSK021)

Tuesday, December 05, 2023

Abbisko Therapeutics has recently entered into a licensing agreement with Merck a prominent science and technology company headquartered in Darmstadt Germany The agreement grants Merck

FDA Approves IND for Carsgen's CT071 in the Treatment of Relapsed/refractory Multiple Myeloma and Relapsed/refractory Primary Plasma Cell Leukemia

Tuesday, December 05, 2023

CARsgen Therapeutics Holdings Limited has obtained Investigational New Drug clearance from the US Food and Drug Administration

Everest Medicines Receives Approval for Investigational New Drug Application of Zetomipzomib in China

Monday, December 04, 2023

Everest Medicines has recently obtained approval from the China National Medical Products Administration NMPA for its investigational new drug application concerning

Psychogenics Has Acquired the Exclusive Global License for an IND-ready ENT1 Inhibitor Designed for the Treatment of Neuropsychiatric Disorders

Saturday, December 02, 2023

PGI Drug Discovery LLC trading as PsychoGenics recently secured an exclusive license agreement with Roche for the global development manufacturing and commercialization rights to RO

Everest Medicines Announces the Approval of New Drug Applications for Nefecon® in the Treatment of Primary IGA Nephropathy Among Adult Patients in South Korea

Friday, December 01, 2023

Everest Medicines a biopharmaceutical firm specializing in the development manufacturing and commercialization of innovative medicines and vaccines has revealed that its New Drug Application

Ascendis Pharma and Teijin Limited Establish Strategic Collaboration in Japan

Thursday, November 30, 2023

Ascendis Pharma AS has recently revealed an exclusive license agreement with Teijin Limited to advance the development and commercialization of TransCon hGH TransCon PTH and TransCon CNP specifically targeting endocrinology rare diseases in Japan

Prism Biolab and Lilly Collaborate in Drug Discovery Aimed at Protein-protein Interaction Target

Wednesday, November 29, 2023

PRISM Biolab Co Ltd a prominent biotechnology company specializing in the development of small molecule inhibitors for proteinprotein interaction targets has officially announced a License and Collaboration Agreement

Gracell Biotechnologies' FasTCAR-T GC012F Receives FDA Clearance for Phase 1/2 Trial in Refractory Systemic Lupus Erythematosus

Tuesday, November 28, 2023

Gracell Biotechnologies Inc has received approval from the US Food and Drug Administration for its Investigational New Drug application allowing the initiation of a Phase clinical trial